Literature DB >> 1592098

Occurrence of monoclonal components in general practice: clinical implications.

F Aguzzi1, M R Bergami, C Gasparro, V Bellotti, G Merlini.   

Abstract

We report on the occurrence of monoclonal components observed in a provincial hospital in northern Italy from 1987 to 1990. The monoclonal components were detected by visual inspection of high-resolution acetate serum electrophoreses and typed by immunofixation. The percentage of monoclonal components increases steeply with age, and reaches a plateau of 7-8% in individuals over 55 years old. Besides the high percentage of monoclonal component, the other relevant finding of this study is that approximately 80% of monoclonal components are of low concentration (less than 5 g/l). Most of these subjects with small monoclonal component passed undetected in the previous studies on the prognostic significance of monoclonal gammapathy. These findings indicate the need for a revision of the current concepts on the biological and clinical significance of MC discovered by chance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592098     DOI: 10.1111/j.1600-0609.1992.tb01584.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  9 in total

1.  An overview of monoclonal gammapathies.

Authors:  T Malati
Journal:  Indian J Clin Biochem       Date:  2001-01

2.  Phenotypic and genotypic alterations characterize patients bearing plasma cell dyscrasias with a high M-component.

Authors:  C Greco; F Ameglio; F Alvino; A Mosiello; A M Cianciulli; I Venturo; G Del Monte; M Giampaolo; A W Tong; G M Gandolfo
Journal:  Cell Prolif       Date:  1999-08       Impact factor: 6.831

3.  The relationship between hypogammaglobulinemia, monoclonal gammopathy of undetermined significance and humoral immunodeficiency: a case series.

Authors:  Robert Marc Zemble; Patricia A Takach; Arnold I Levinson
Journal:  J Clin Immunol       Date:  2011-06-05       Impact factor: 8.317

Review 4.  Prevalence, clinical aspects, and natural history of IgM MGUS.

Authors:  Mary L McMaster; Ola Landgren
Journal:  Cytometry B Clin Cytom       Date:  2010       Impact factor: 3.058

Review 5.  Prevalence of monoclonal gammopathy of undetermined significance: a systematic review.

Authors:  Rishi K Wadhera; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2010-08-16       Impact factor: 7.616

Review 6.  Systemic amyloidoses.

Authors:  Luis M Blancas-Mejía; Marina Ramirez-Alvarado
Journal:  Annu Rev Biochem       Date:  2013-02-28       Impact factor: 23.643

7.  Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.

Authors:  M Ocqueteau; A Orfao; J Almeida; J Bladé; M González; R García-Sanz; C López-Berges; M J Moro; J Hernández; L Escribano; D Caballero; M Rozman; J F San Miguel
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

8.  Spectrum of monoclonal gammapathies in Andhra Pradesh.

Authors:  T Malati; B Yadagiri; D M Krishna; V Shantaram; D Raghunadharao; K Subbarao
Journal:  Indian J Clin Biochem       Date:  2001-01

9.  Transient paraproteinemia after allogeneic hematopoietic stem cell transplantation is an underexplored phenomenon associated with graft versus host disease.

Authors:  Corinne C Widmer; Stefan Balabanov; Urs Schanz; Alexandre P A Theocharides
Journal:  Oncotarget       Date:  2017-11-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.